AU2021213131B2 - Systems and methods for processing electronic images for biomarker localization - Google Patents
Systems and methods for processing electronic images for biomarker localization Download PDFInfo
- Publication number
- AU2021213131B2 AU2021213131B2 AU2021213131A AU2021213131A AU2021213131B2 AU 2021213131 B2 AU2021213131 B2 AU 2021213131B2 AU 2021213131 A AU2021213131 A AU 2021213131A AU 2021213131 A AU2021213131 A AU 2021213131A AU 2021213131 B2 AU2021213131 B2 AU 2021213131B2
- Authority
- AU
- Australia
- Prior art keywords
- tumor
- training
- region
- digital images
- machine learning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 182
- 239000000090 biomarker Substances 0.000 title claims abstract description 136
- 230000004807 localization Effects 0.000 title description 31
- 238000012545 processing Methods 0.000 title description 14
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 216
- 230000007170 pathology Effects 0.000 claims abstract description 89
- 238000010801 machine learning Methods 0.000 claims abstract description 83
- 238000011282 treatment Methods 0.000 claims abstract description 55
- 238000012549 training Methods 0.000 claims description 91
- 230000014509 gene expression Effects 0.000 claims description 23
- 238000012360 testing method Methods 0.000 claims description 20
- 238000003364 immunohistochemistry Methods 0.000 claims description 16
- 230000015654 memory Effects 0.000 claims description 11
- 230000002068 genetic effect Effects 0.000 claims description 9
- 238000000684 flow cytometry Methods 0.000 claims description 7
- 210000001519 tissue Anatomy 0.000 description 98
- 238000003860 storage Methods 0.000 description 56
- 201000011510 cancer Diseases 0.000 description 27
- 238000001514 detection method Methods 0.000 description 21
- 238000004458 analytical method Methods 0.000 description 17
- 108090000623 proteins and genes Proteins 0.000 description 15
- 230000035772 mutation Effects 0.000 description 14
- 239000003550 marker Substances 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 238000004891 communication Methods 0.000 description 11
- 238000003745 diagnosis Methods 0.000 description 11
- 230000000118 anti-neoplastic effect Effects 0.000 description 10
- 238000013527 convolutional neural network Methods 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 238000009169 immunotherapy Methods 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- 230000004044 response Effects 0.000 description 9
- 230000000007 visual effect Effects 0.000 description 9
- 206010064571 Gene mutation Diseases 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 238000002372 labelling Methods 0.000 description 7
- 238000013528 artificial neural network Methods 0.000 description 6
- 238000004422 calculation algorithm Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000004547 gene signature Effects 0.000 description 6
- 230000011218 segmentation Effects 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 5
- 210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 description 5
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000013473 artificial intelligence Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000037406 food intake Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000007901 in situ hybridization Methods 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 230000002018 overexpression Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000000306 recurrent effect Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 238000012706 support-vector machine Methods 0.000 description 4
- 101001117317 Homo sapiens Programmed cell death 1 ligand 1 Proteins 0.000 description 3
- 208000032818 Microsatellite Instability Diseases 0.000 description 3
- 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000007637 random forest analysis Methods 0.000 description 3
- 238000002626 targeted therapy Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 241000282412 Homo Species 0.000 description 2
- 238000003559 RNA-seq method Methods 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000000890 drug combination Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
- 238000012268 genome sequencing Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000002962 histologic effect Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000010166 immunofluorescence Methods 0.000 description 2
- 238000013394 immunophenotyping Methods 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 238000002493 microarray Methods 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000013517 stratification Methods 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- 206010069754 Acquired gene mutation Diseases 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 description 1
- 101000934372 Homo sapiens Macrosialin Proteins 0.000 description 1
- 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 description 1
- 101000652359 Homo sapiens Spermatogenesis-associated protein 2 Proteins 0.000 description 1
- 229940076838 Immune checkpoint inhibitor Drugs 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102100025136 Macrosialin Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101100273740 Mus musculus Cd68 gene Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108020004518 RNA Probes Proteins 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- 238000012896 Statistical algorithm Methods 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000011394 anticancer treatment Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000003560 cancer drug Substances 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013135 deep learning Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000003709 image segmentation Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000012274 immune-checkpoint protein inhibitor Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 238000010603 microCT Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000003058 natural language processing Methods 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 239000000101 novel biomarker Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000037439 somatic mutation Effects 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000007794 visualization technique Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/0002—Inspection of images, e.g. flaw detection
- G06T7/0012—Biomedical image inspection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/20—Special algorithmic details
- G06T2207/20081—Training; Learning
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/20—Special algorithmic details
- G06T2207/20084—Artificial neural networks [ANN]
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/30—Subject of image; Context of image processing
- G06T2207/30004—Biomedical image processing
- G06T2207/30024—Cell structures in vitro; Tissue sections in vitro
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/30—Subject of image; Context of image processing
- G06T2207/30004—Biomedical image processing
- G06T2207/30096—Tumor; Lesion
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H30/00—ICT specially adapted for the handling or processing of medical images
- G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Data Mining & Analysis (AREA)
- Biomedical Technology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Databases & Information Systems (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Physics & Mathematics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Quality & Reliability (AREA)
- Image Analysis (AREA)
- Image Processing (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062966723P | 2020-01-28 | 2020-01-28 | |
| US62/966,723 | 2020-01-28 | ||
| PCT/US2021/015323 WO2021154878A1 (fr) | 2020-01-28 | 2021-01-27 | Systèmes et procédés de traitement d'images électroniques pour la localisation de biomarqueurs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2021213131A1 AU2021213131A1 (en) | 2022-09-01 |
| AU2021213131B2 true AU2021213131B2 (en) | 2023-02-02 |
Family
ID=74853705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021213131A Active AU2021213131B2 (en) | 2020-01-28 | 2021-01-27 | Systems and methods for processing electronic images for biomarker localization |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US11182900B2 (fr) |
| EP (1) | EP4097738A1 (fr) |
| JP (1) | JP7376882B2 (fr) |
| CN (1) | CN114981899A (fr) |
| AU (1) | AU2021213131B2 (fr) |
| CA (1) | CA3161533C (fr) |
| WO (1) | WO2021154878A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3963508B1 (fr) * | 2019-05-03 | 2024-09-18 | Huron Technologies International Inc. | Système de diagnostic d'images, et ses procédés d'exploitation |
| EP4097738A1 (fr) * | 2020-01-28 | 2022-12-07 | PAIGE.AI, Inc. | Systèmes et procédés de traitement d'images électroniques pour la localisation de biomarqueurs |
| US20230116379A1 (en) | 2021-09-24 | 2023-04-13 | PAIGE.AI, Inc. | Systems and methods to process electronic images to identify tumor subclones and relationships among subclones |
| US20230307137A1 (en) * | 2022-03-25 | 2023-09-28 | GE Precision Healthcare LLC | System and method for detecting recurrence of a disease |
| CN115330949B (zh) * | 2022-08-16 | 2024-04-05 | 中山大学附属第一医院 | 一种肝细胞癌侵袭边缘预测方法及系统 |
| CN115295154B (zh) * | 2022-10-08 | 2023-02-03 | 北京肿瘤医院(北京大学肿瘤医院) | 肿瘤免疫治疗疗效预测方法、装置、电子设备及存储介质 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160123964A1 (en) * | 2014-11-05 | 2016-05-05 | The Regents Of The University Of California | Methods for stratifying non-responders to therapies that block pd1/pdl1 axis |
| US20190113423A1 (en) * | 2015-12-02 | 2019-04-18 | Clearlight Diagnostics, LLC | Methods for preparing and analyzing tumor tissue samples for detection and monitoring of cancers |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3365682B1 (fr) * | 2015-10-23 | 2020-10-07 | Novartis AG | Système permettant d'obtenir des proximités spatiales de cellule à cellule |
| AU2016369603A1 (en) * | 2015-12-18 | 2018-07-05 | Clear Gene, Inc. | Methods, compositions, kits and devices for rapid analysis of biological markers |
| KR102511024B1 (ko) * | 2016-03-15 | 2023-03-16 | 오리존 지노믹스 에스.에이. | 고형 종양의 치료에 사용하기 위한 lsd1 억제제의 조합물 |
| WO2017198790A1 (fr) * | 2016-05-18 | 2017-11-23 | F. Hoffmann-La Roche Ag | Mesure de proximité de tumeur |
| US10282588B2 (en) * | 2016-06-09 | 2019-05-07 | Siemens Healthcare Gmbh | Image-based tumor phenotyping with machine learning from synthetic data |
| EP3523779A1 (fr) | 2016-10-07 | 2019-08-14 | Ventana Medical Systems, Inc. | Système de pathologie numérique et flux de travail associé pour fournir une analyse d'image à glissement total visualisée |
| WO2018086985A1 (fr) | 2016-11-10 | 2018-05-17 | F. Hoffmann-La Roche Ag | Classification de tumeur basée sur la distance |
| US11835524B2 (en) | 2017-03-06 | 2023-12-05 | University Of Southern California | Machine learning for digital pathology |
| GB2567155B (en) * | 2017-10-02 | 2022-03-02 | Room4 Group Ltd | Histopathological image analysis |
| WO2019100032A2 (fr) * | 2017-11-17 | 2019-05-23 | Mayo Foundation For Medical Education And Research | Procédés d'utilisation de modèles d'apprentissage automatique et mécanistes pour la cartographie de caractéristiques biologiques avec irm multiparamétrique |
| US10748040B2 (en) * | 2017-11-20 | 2020-08-18 | Kavya Venkata Kota Sai KOPPARAPU | System and method for automatic assessment of cancer |
| EP3752979A1 (fr) | 2018-02-12 | 2020-12-23 | F. Hoffmann-La Roche AG | Transformation d'images numériques de pathologie |
| EP3769282B1 (fr) | 2018-03-23 | 2023-08-23 | Memorial Sloan Kettering Cancer Center | Systèmes et procédés d'apprentissage à instances multiples pour la classification et la localisation dans l'imagerie biomédicale |
| CA3133826A1 (fr) | 2019-03-26 | 2020-10-01 | Tempus Labs, Inc. | Determination de biomarqueurs a partir d'images de lames histopathologiques |
| EP4097738A1 (fr) * | 2020-01-28 | 2022-12-07 | PAIGE.AI, Inc. | Systèmes et procédés de traitement d'images électroniques pour la localisation de biomarqueurs |
-
2021
- 2021-01-27 EP EP21709508.2A patent/EP4097738A1/fr active Pending
- 2021-01-27 CA CA3161533A patent/CA3161533C/fr active Active
- 2021-01-27 CN CN202180011452.8A patent/CN114981899A/zh active Pending
- 2021-01-27 AU AU2021213131A patent/AU2021213131B2/en active Active
- 2021-01-27 WO PCT/US2021/015323 patent/WO2021154878A1/fr unknown
- 2021-01-27 JP JP2022544332A patent/JP7376882B2/ja active Active
- 2021-01-27 US US17/160,127 patent/US11182900B2/en active Active
- 2021-11-04 US US17/519,106 patent/US11481898B2/en active Active
-
2022
- 2022-09-21 US US17/934,062 patent/US20230025189A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160123964A1 (en) * | 2014-11-05 | 2016-05-05 | The Regents Of The University Of California | Methods for stratifying non-responders to therapies that block pd1/pdl1 axis |
| US20190113423A1 (en) * | 2015-12-02 | 2019-04-18 | Clearlight Diagnostics, LLC | Methods for preparing and analyzing tumor tissue samples for detection and monitoring of cancers |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021154878A1 (fr) | 2021-08-05 |
| US20220130041A1 (en) | 2022-04-28 |
| CA3161533A1 (fr) | 2021-08-05 |
| AU2021213131A1 (en) | 2022-09-01 |
| US11481898B2 (en) | 2022-10-25 |
| JP2023506579A (ja) | 2023-02-16 |
| JP7376882B2 (ja) | 2023-11-09 |
| CA3161533C (fr) | 2023-08-29 |
| US20210233236A1 (en) | 2021-07-29 |
| US11182900B2 (en) | 2021-11-23 |
| EP4097738A1 (fr) | 2022-12-07 |
| CN114981899A (zh) | 2022-08-30 |
| US20230025189A1 (en) | 2023-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11893510B2 (en) | Systems and methods for processing images to classify the processed images for digital pathology | |
| US11995903B2 (en) | Systems and methods for processing electronic images for computational detection methods | |
| AU2021213131B2 (en) | Systems and methods for processing electronic images for biomarker localization | |
| US11107573B2 (en) | Systems and methods for processing electronic images for generalized disease detection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |